Neuroimmune, metabolic and oxidative stress pathways in major depressive disorder
- PMID: 40659853
- DOI: 10.1038/s41582-025-01116-4
Neuroimmune, metabolic and oxidative stress pathways in major depressive disorder
Abstract
This Review examines the role of neuroimmune imbalances and their relationship with metabolism and oxidative stress in the development and progression of major depressive disorder (MDD) and suicidal behaviours. We provide a concise overview of the neuroinflammatory environment and indicators of neuronal injury in the central nervous system of individuals with MDD. Furthermore, we explore the evidence for perturbations in both the peripheral and central immune system, T cell activation versus T regulatory cell depletion, intracellular signalling networks including nuclear factor-κB, lipid metabolism and neuroprotection. Last, we examine the mechanisms by which psychological stressors, translocation of Gram-negative bacteria, viral infections such as SARS-CoV-2 and metabolic syndrome can contribute to neuroimmune imbalances and, consequently, the acute phase of MDD.
© 2025. Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Stress-induced heme metabolic disorder in peripheral B cells contributes to depressive-like behaviors in male mice.Prog Neurobiol. 2025 Aug;251:102800. doi: 10.1016/j.pneurobio.2025.102800. Epub 2025 Jun 21. Prog Neurobiol. 2025. PMID: 40544657
-
Omega-3 fatty acids for depression in adults.Cochrane Database Syst Rev. 2021 Nov 24;11(11):CD004692. doi: 10.1002/14651858.CD004692.pub5. Cochrane Database Syst Rev. 2021. PMID: 34817851 Free PMC article.
-
Omega-3 fatty acids for depression in adults.Cochrane Database Syst Rev. 2015 Nov 5;2015(11):CD004692. doi: 10.1002/14651858.CD004692.pub4. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Nov 24;11:CD004692. doi: 10.1002/14651858.CD004692.pub5. PMID: 26537796 Free PMC article. Updated.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- World Health Organization. Depression. WHO https://www.who.int/news-room/fact-sheets/detail/depression (2023).
-
- Citrome, L. et al. Prevalence, treatment patterns, and stay characteristics associated with hospitalizations for major depressive disorder. J. Affect. Disord. 249, 378–384 (2019). - PubMed
-
- Cosci, F. & Fava, G. A. Staging of mental disorders: systematic review. Psychother. Psychosom. 82, 20–34 (2012). - PubMed
-
- Maes, M. et al. Development of a novel staging model for affective disorders using partial least squares bootstrapping: effects of lipid-associated antioxidant defenses and neuro-oxidative stress. Mol. Neurobiol. 56, 6626–6644 (2019). - PubMed
-
- Maes, M., Kubera, M., Obuchowiczwa, E., Goehler, L. & Brzeszcz, J. Depression’s multiple comorbidities explained by (neuro)inflammatory and oxidative and nitrosative stress pathways. Neuro Endocrinol. Lett. 32, 7–24 (2011). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous